The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Immunoglobulin Market Research Report 2025

Global Immunoglobulin Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 166069

No of Pages : 99

Synopsis
The global Immunoglobulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Immunoglobulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immunoglobulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Immunoglobulin include Baxter, CSL, Grifols, Octapharma, Biotest, China National Pharmaceutical Group, CTBB, Hualan Bio and RAAS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunoglobulin.
Report Scope
The Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
CSL
Grifols
Octapharma
Biotest
China National Pharmaceutical Group
CTBB
Hualan Bio
RAAS
Shanxi Kangbao Biological
Shuanglin Bio Pharm
Sichuan Yuanda Shuyang Pharmaceutical
Boya Bio
Jiade Bio
Weilun Bio
Segment by Type
Intramuscular Injection Human Immunoglobulin
Intravenous Injection Human Immunoglobulin
Segment by Application
Prevention of Measles
Infectious Hepatitis
Primary Immunoglobulin Deficiency
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Immunoglobulin Market Overview
1.1 Product Overview and Scope of Immunoglobulin
1.2 Immunoglobulin Segment by Type
1.2.1 Global Immunoglobulin Market Value Comparison by Type (2024-2030)
1.2.2 Intramuscular Injection Human Immunoglobulin
1.2.3 Intravenous Injection Human Immunoglobulin
1.3 Immunoglobulin Segment by Application
1.3.1 Global Immunoglobulin Market Value by Application: (2024-2030)
1.3.2 Prevention of Measles
1.3.3 Infectious Hepatitis
1.3.4 Primary Immunoglobulin Deficiency
1.4 Global Immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Immunoglobulin Revenue 2019-2030
1.4.2 Global Immunoglobulin Sales 2019-2030
1.4.3 Global Immunoglobulin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Immunoglobulin Market Competition by Manufacturers
2.1 Global Immunoglobulin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Immunoglobulin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Immunoglobulin Average Price by Manufacturers (2019-2024)
2.4 Global Immunoglobulin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immunoglobulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immunoglobulin, Product Type & Application
2.7 Immunoglobulin Market Competitive Situation and Trends
2.7.1 Immunoglobulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Immunoglobulin Players Market Share by Revenue
2.7.3 Global Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Immunoglobulin Retrospective Market Scenario by Region
3.1 Global Immunoglobulin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Immunoglobulin Global Immunoglobulin Sales by Region: 2019-2030
3.2.1 Global Immunoglobulin Sales by Region: 2019-2024
3.2.2 Global Immunoglobulin Sales by Region: 2025-2030
3.3 Global Immunoglobulin Global Immunoglobulin Revenue by Region: 2019-2030
3.3.1 Global Immunoglobulin Revenue by Region: 2019-2024
3.3.2 Global Immunoglobulin Revenue by Region: 2025-2030
3.4 North America Immunoglobulin Market Facts & Figures by Country
3.4.1 North America Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Immunoglobulin Sales by Country (2019-2030)
3.4.3 North America Immunoglobulin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Immunoglobulin Market Facts & Figures by Country
3.5.1 Europe Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Immunoglobulin Sales by Country (2019-2030)
3.5.3 Europe Immunoglobulin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immunoglobulin Market Facts & Figures by Country
3.6.1 Asia Pacific Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Immunoglobulin Sales by Country (2019-2030)
3.6.3 Asia Pacific Immunoglobulin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Immunoglobulin Market Facts & Figures by Country
3.7.1 Latin America Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Immunoglobulin Sales by Country (2019-2030)
3.7.3 Latin America Immunoglobulin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immunoglobulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Immunoglobulin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Immunoglobulin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immunoglobulin Sales by Type (2019-2030)
4.1.1 Global Immunoglobulin Sales by Type (2019-2024)
4.1.2 Global Immunoglobulin Sales by Type (2025-2030)
4.1.3 Global Immunoglobulin Sales Market Share by Type (2019-2030)
4.2 Global Immunoglobulin Revenue by Type (2019-2030)
4.2.1 Global Immunoglobulin Revenue by Type (2019-2024)
4.2.2 Global Immunoglobulin Revenue by Type (2025-2030)
4.2.3 Global Immunoglobulin Revenue Market Share by Type (2019-2030)
4.3 Global Immunoglobulin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Immunoglobulin Sales by Application (2019-2030)
5.1.1 Global Immunoglobulin Sales by Application (2019-2024)
5.1.2 Global Immunoglobulin Sales by Application (2025-2030)
5.1.3 Global Immunoglobulin Sales Market Share by Application (2019-2030)
5.2 Global Immunoglobulin Revenue by Application (2019-2030)
5.2.1 Global Immunoglobulin Revenue by Application (2019-2024)
5.2.2 Global Immunoglobulin Revenue by Application (2025-2030)
5.2.3 Global Immunoglobulin Revenue Market Share by Application (2019-2030)
5.3 Global Immunoglobulin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Immunoglobulin Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Immunoglobulin Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Immunoglobulin Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Immunoglobulin Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Corporation Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biotest Immunoglobulin Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 China National Pharmaceutical Group
6.6.1 China National Pharmaceutical Group Corporation Information
6.6.2 China National Pharmaceutical Group Description and Business Overview
6.6.3 China National Pharmaceutical Group Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 China National Pharmaceutical Group Immunoglobulin Product Portfolio
6.6.5 China National Pharmaceutical Group Recent Developments/Updates
6.7 CTBB
6.6.1 CTBB Corporation Information
6.6.2 CTBB Description and Business Overview
6.6.3 CTBB Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CTBB Immunoglobulin Product Portfolio
6.7.5 CTBB Recent Developments/Updates
6.8 Hualan Bio
6.8.1 Hualan Bio Corporation Information
6.8.2 Hualan Bio Description and Business Overview
6.8.3 Hualan Bio Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hualan Bio Immunoglobulin Product Portfolio
6.8.5 Hualan Bio Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Corporation Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 RAAS Immunoglobulin Product Portfolio
6.9.5 RAAS Recent Developments/Updates
6.10 Shanxi Kangbao Biological
6.10.1 Shanxi Kangbao Biological Corporation Information
6.10.2 Shanxi Kangbao Biological Description and Business Overview
6.10.3 Shanxi Kangbao Biological Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanxi Kangbao Biological Immunoglobulin Product Portfolio
6.10.5 Shanxi Kangbao Biological Recent Developments/Updates
6.11 Shuanglin Bio Pharm
6.11.1 Shuanglin Bio Pharm Corporation Information
6.11.2 Shuanglin Bio Pharm Immunoglobulin Description and Business Overview
6.11.3 Shuanglin Bio Pharm Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shuanglin Bio Pharm Immunoglobulin Product Portfolio
6.11.5 Shuanglin Bio Pharm Recent Developments/Updates
6.12 Sichuan Yuanda Shuyang Pharmaceutical
6.12.1 Sichuan Yuanda Shuyang Pharmaceutical Corporation Information
6.12.2 Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Description and Business Overview
6.12.3 Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Product Portfolio
6.12.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments/Updates
6.13 Boya Bio
6.13.1 Boya Bio Corporation Information
6.13.2 Boya Bio Immunoglobulin Description and Business Overview
6.13.3 Boya Bio Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Boya Bio Immunoglobulin Product Portfolio
6.13.5 Boya Bio Recent Developments/Updates
6.14 Jiade Bio
6.14.1 Jiade Bio Corporation Information
6.14.2 Jiade Bio Immunoglobulin Description and Business Overview
6.14.3 Jiade Bio Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jiade Bio Immunoglobulin Product Portfolio
6.14.5 Jiade Bio Recent Developments/Updates
6.15 Weilun Bio
6.15.1 Weilun Bio Corporation Information
6.15.2 Weilun Bio Immunoglobulin Description and Business Overview
6.15.3 Weilun Bio Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Weilun Bio Immunoglobulin Product Portfolio
6.15.5 Weilun Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immunoglobulin Industry Chain Analysis
7.2 Immunoglobulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immunoglobulin Production Mode & Process
7.4 Immunoglobulin Sales and Marketing
7.4.1 Immunoglobulin Sales Channels
7.4.2 Immunoglobulin Distributors
7.5 Immunoglobulin Customers
8 Immunoglobulin Market Dynamics
8.1 Immunoglobulin Industry Trends
8.2 Immunoglobulin Market Drivers
8.3 Immunoglobulin Market Challenges
8.4 Immunoglobulin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’